Cell Source, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cell Source, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $131.25K.
- Cell Source, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-03-31 was $56.88K, a 94.78% decline year-over-year.
- Cell Source, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-03-31 was $1.09M.
- Cell Source, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $188.13K.
- Cell Source, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $573.75K, a 72.84% decline from fiscal 2017.
- Cell Source, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $2.11M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2020-12-31 | $188.13K 10-K · filed 2022-04-15 | |
| 2020-06-30 | $131.25K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $56.88K 10-Q · filed 2021-11-15 | |
| 2019-03-31 | $1.09M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $573.75K 10-K · filed 2019-04-01 | |
| 2017-12-31 | $2.11M 10-K · filed 2019-04-01 |